These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12527176)

  • 1. Matrix formation in sustained release tablets: possible mechanism of dose dumping.
    Krajacic A; Tucker IG
    Int J Pharm; 2003 Jan; 251(1-2):67-78. PubMed ID: 12527176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Matrix Technology on the Subdivision of Sustained Release Matrix Tablets.
    Teixeira MT; Sa-Barreto LL; Taveira SF; Gratieri T; Gelfuso GM; Marreto RN; Silva IC; Cunha-Filho M
    AAPS PharmSciTech; 2019 Dec; 21(1):8. PubMed ID: 31797144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulating drug release behavior and kinetics from matrix tablets based on fine particle-sized ethyl cellulose ether derivatives: an in vitro and in vivo evaluation.
    Shah KU; Khan GM
    ScientificWorldJournal; 2012; 2012():842348. PubMed ID: 22649325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanical properties of excipients do not affect polymer matrix formation.
    Chatterjee L; Rades T; Tucker IG
    Int J Pharm; 2010 Jan; 384(1-2):87-92. PubMed ID: 19819317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release matrix tablets of olanzapine: influence of polymers on the in vitro release and bioavailability.
    Badshah A; Subhan F; Rauf K
    AAPS PharmSciTech; 2010 Sep; 11(3):1397-404. PubMed ID: 20824513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpolymer complexation between copovidone and carbopol and its effect on drug release from matrix tablets.
    Zhang F; Meng F; Wang ZY; Na W
    Drug Dev Ind Pharm; 2017 Feb; 43(2):190-203. PubMed ID: 27599027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of gastroretentive sustained release tablets prepared by combination of melt/sublimation actions of L-menthol and penetration of molten polymers into tablets.
    Fukuda M; Goto A
    Chem Pharm Bull (Tokyo); 2011; 59(10):1221-6. PubMed ID: 21963630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and in vitro evaluation of directly compressed controlled release tablets designed from the Co-precipitates.
    Khan KA; Khan GM; Jan SU; Rehman A; Mehsud S
    Pak J Pharm Sci; 2018 Mar; 31(2):455-461. PubMed ID: 29618434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthan gum as a rate-controlling polymer for the development of alcohol resistant matrix tablets and mini-tablets.
    Lazzari A; Kleinebudde P; Knop K
    Int J Pharm; 2018 Jan; 536(1):440-449. PubMed ID: 29225098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
    Van Nguyen H; Nguyen VH; Lee BJ
    Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the Influence of Tablet Location Inside Dissolution Test Apparatus on Polymer Erosion and Drug Release of a Surface-Erodible Sustained-Release Tablet Using Computational Simulation Methods.
    Lou H; Hageman MJ
    AAPS PharmSciTech; 2021 Mar; 22(3):99. PubMed ID: 33709248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of honey locust (Gleditsia triacanthos Linn.) gum as sustaining material in tablet dosage forms.
    Uner M; Altinkurt T
    Farmaco; 2004 Jul; 59(7):567-73. PubMed ID: 15231434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of gastro intestinal sustained release tablet formulation containing acryl-EZE and pH-dependent swelling HPMC K 15 M.
    Lamoudi L; Chaumeil JC; Daoud K
    Drug Dev Ind Pharm; 2012 May; 38(5):515-20. PubMed ID: 21978389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F; Moreno P; Basit AW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Prosopis africana Seed Gum as an Extended Release Polymer for Tablet Formulation.
    Nadaf S; Nnamani P; Jadhav N
    AAPS PharmSciTech; 2015 Jun; 16(3):716-29. PubMed ID: 25523143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of polyvinyl acetate dispersion as a sustained release polymer for tablets.
    Bordaweka MS; Zia H; Quadir A
    Drug Deliv; 2006; 13(2):121-31. PubMed ID: 16423800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the injection mold temperature upon polymer crystallization and resulting drug release from immediate and sustained release tablets.
    Van Renterghem J; Dhondt H; Verstraete G; De Bruyne M; Vervaet C; De Beer T
    Int J Pharm; 2018 Apr; 541(1-2):108-116. PubMed ID: 29409747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.